Sodium Chloride Injection, Solution, Concentrate
NDC Package 0409-6660-25

11-digit billing NDC: 00409666025

Package Information

Sodium Chloride injection is 14.6% Sodium Chloride Injection, USP Additive Solution is indicated for parenteral restoration of sodium ion in patients with restricted oral intake. This formulation utilizes a injection, solution, concentrate delivery system. Marketed by Hospira, Inc., this product is identified by NDC 0409-6660 and is authorized under FDA application NDA018897.

Identification & Billing

NDC Package Code
0409-6660-25
Package Description
25 VIAL, SINGLE-DOSE in 1 CARTON / 40 mL in 1 VIAL, SINGLE-DOSE
Product Code
11-Digit Billing Format
00409666025
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Sodium Chloride
Non-Proprietary Name
Sodium Chloride
Substance Name
Sodium Chloride
Dosage Form
Injection, Solution, Concentrate - A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Usage Information
14.6% Sodium Chloride Injection, USP Additive Solution is indicated for parenteral restoration of sodium ion in patients with restricted oral intake. Sodium replacement is specifically indicated in patients with hyponatremia or low salt syndrome. 14.6% Sodium Chloride Additive Solution may also be added to compatible carbohydrate solutions such as dextrose in water to provide electrolytes.

Regulatory & Marketing

Labeler Name
Hospira, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA018897
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-29-2005
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0409-6660). Click a package code to view its specific billing and regulatory data.

25 VIAL in 1 TRAY / 40 mL in 1 VIAL (0409-6660-01)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0409-6660-25 identifies a specific commercial package of 25 vial, single-dose in 1 carton / 40 ml in 1 vial, single-dose of Sodium Chloride, a human prescription drug labeled by Hospira, Inc.. This injection, solution, concentrate is formulated for intravenous use and contains sodium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hospira, Inc. on July 29, 2005. The current certification is valid through December 31, 2027.

How is this Hospira, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00409666025. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0409-6660-25
11-Digit CMS (5-4-2)
00409-6660-25

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.